Futura Medical PLC (LON:FUM) said it will host a research and development day on February 11 in London.
The event will feature a presentation from a key opinion leader in erectile dysfunction.
It will also provide an opportunity to hear about the company and its R&D strategy with a focus on its DermaSys drug delivery technology and lead product MED2005, a gel for the treatment of erectile dysfunction.
For further information on the R&D day, or to register your interest, contact Optimum Strategic Communications at futuramedical@optimumcomms.com.